Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Minoxidil helps hair regrowth in alopecia, but more research needed.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

The document explains the genetic causes and characteristics of inherited hair disorders.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Type I interferons play a key role in the development of various skin diseases.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Low vitamin D levels are common in people with Alopecia Areata.

Alopecia areata does not affect areas with psoriasis plaques.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Detailed history and physical examination are crucial for diagnosing hair loss.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.